Elsevier

Human Pathology

Volume 23, Issue 1, January 1992, Pages 57-62
Human Pathology

The pathologic spectrum of the nephropathy associated with α1-antitrypsin deficiency

https://doi.org/10.1016/0046-8177(92)90012-RGet rights and content

To further define the clinicopathologic spectrum and pathogenetic mechanism of the nephropathy associated with α1-antitrypsin (A1AT) deficiency, we evaluated renal specimens from 34 patients with chronic hepatic disease, including 20 with A1AT deficiency (study patients), and correlated these findings with urinalysis evaluation. Glomerular lesions were noted in 79% (15 of 19) of A1AT patients with the PiZZ phenotype, including seven with mesangiocapillary glomerulonephritis (MPGN and focal segmental MPGN), six with mesangial proliferative glomerulonephritis (Mes GN), one with diffuse endocapillary proliferative glomerulonephritis (DPGN), and one with focal segmental mesangial proliferative glomerulonephritis with segmental necrosis (FS Nec GN). One A1AT patient with the PiMZ phenotype did not demonstrate glomerular abnormalities. Focal segmental Mes GN was found in 43% (six of 14) of patients in an age-matched group with chronic hepatic failure unrelated to A1AT deficiency. In nine study patients, glomerular pathology was noted in the presence of a normal urinalysis. Immunofluorescence studies revealed the presence of immunoproteins and the A1AT protein isoelectric forms, PiM and PiZ, in the subendothelial region of glomerular basement membranes in A1AT patients with MPGN, Mes GN, and DPGN. Our results emphasize the heterogeneity of glomerular lesions associated with A1AT deficiency and hepatic disease and the relatively high incidence of MPGN in these children. The presence of abnormal PiZ protein in the subendothelial region of the glomerular basement membrane in A1AT patients with glomerulonephritis suggests a possible role for this protein in the pathogenesis of this lesion.

References (29)

  • ChurgJ

    WHO Classification and Atlas of Glomerular Diseases

  • BergerJ et al.

    Glomerular changes in patients with cirrhosis of the liver

    Adv Nephrol

    (1978)
  • CallardP et al.

    Immune complex type glomerulonephritis in cirrhosis of the liver

    Am J Pathol

    (1975)
  • BloodworthJM et al.

    “Cirrhotic glomerulosclerosis,” a renal lesion associated with hepatic cirrhosis

    Lab Invest

    (1959)
  • Cited by (58)

    • Application of directed evolution and back-to-consensus algorithms to human alpha1-antitrypsin leads to diminished anti-protease activity and augmented anti-inflammatory activities

      2020, Cellular Immunology
      Citation Excerpt :

      Clinically, hAAT is mostly associated with its genetic deficiency (AATD), a condition associated with early-onset lung emphysema in smokers and non-smokers, as well as liver cirrhosis [11,12]. However, recent data suggests an increased risk for other comorbidities, such as vasculitis [13], bacterial pneumonia [14], cervical artery dissection [15], type II diabetes mellitus [16], HIV infection [17], glomerulonephritis [18], poor wound healing [19] and even mood disorders [20]. Currently, the sole clinically approved therapy for AATD is the life-long weekly infusion of serum-purified hAAT (sp-hAAT), recently found to slow the progression of pulmonary emphysema [21].

    • Transplantation for Metabolic Disease in Children

      2015, Transplantation of the Liver: Third Edition
    • Genetic and metabolic liver disease

      2012, MacSween's Pathology of the Liver
    • Genetic and Metabolic Liver Disease

      2011, MacSween's Pathology of the Liver: Expert Consult: Online and Print
    • The discovery of α1-antitrypsin and its role in health and disease

      2011, Respiratory Medicine
      Citation Excerpt :

      Several reports have described AATD patients having both liver disease and rheumatoid arthritis100 and larger studies from Canada and Sweden have shown an increased frequency of AATD phenotypes in patients with rheumatoid arthritis compared to population frequencies.101,102 In addition, in the setting of AATD-associated chronic liver disease, renal disease is often seen in children and young adults.103,104 Numerous reports have also associated AATD and pancreatitis, inflammatory bowel disease, celiac disease, peptic ulcer disease, fibromuscular dysplasia, aneurysms and coronary atherosclerosis.

    View all citing articles on Scopus

    Supported by a contract with the National Institutes of Health (DK 62274), by grants from the National Institutes of Health (AI 10704, DK 07087, and DK 34931), and by a grant from the Viking Children's Fund, I.D.D. is a recipient of the Burroughs Wellcome Fellowship Award, National Kidney Foundation, Inc.

    View full text